Gain of 1q is a marker of poor prognosis in Wilms' tumors

Treatment and outcome of Wilms' tumour patients: an analysis of all cases registered in the UKW3 trial

(2012) K. Pritchard-Jones et al.   ANNALS OF ONCOLOGY

Genomic profiling by whole-genome single nucleotide polymorphism arrays in Wilms tumor and association with relapse

(2012) Daniela Perotti et al.   GENES CHROMOSOMES & CANCER

Loss of Heterozygosity Analysis at Different Chromosome Regions in Wilms Tumor Confirms 1p Allelic Loss as a Marker of Worse Prognosis: A Study from the Italian Association of Pediatric Hematology and Oncology

(2012) Filippo Spreafico et al.   JOURNAL OF UROLOGY

Children's Oncology Group's 2013 blueprint for research: Renal tumors

(2012) Jeffrey S. Dome et al.   PEDIATRIC BLOOD & CANCER

SNP-based arrays complement classic cytogenetics in the detection of chromosomal aberrations in Wilms’ tumor

(2012) Reena Zin et al.   Cancer Genetics

A Multilocus Technique for Risk Evaluation of Patients with Neuroblastoma

(2011) I. M. Ambros et al.   CLINICAL CANCER RESEARCH

The contribution of chest CT-scan at diagnosis in children with unilateral Wilms’ tumour. Results of the SIOP 2001 study

(2011) Anne M.J.B. Smets et al.   EUROPEAN JOURNAL OF CANCER

Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in wilms tumor

(2011) Richard D. Williams et al.   GENES CHROMOSOMES & CANCER

Analysis of Wilms Tumors Using SNP Mapping Array-Based Comparative Genomic Hybridization

(2011) Lesleyann Hawthorn et al.   PLoS One

Subtype-Specific FBXW7 Mutation and MYCN Copy Number Gain in Wilms' Tumor

(2010) R. D. Williams et al.   CLINICAL CANCER RESEARCH

Cytogenetic findings in Wilms’ tumour: a single institute study

(2010) Reena MdZin et al.   PATHOLOGY

Central pathology review in multicenter trials and studies

(2009) Gordan M. Vujanić et al.   CANCER

Predicting Relapse in Favorable Histology Wilms Tumor Using Gene Expression Analysis: A Report from the Renal Tumor Committee of the Children's Oncology Group

(2009) C.-C. Huang et al.   CLINICAL CANCER RESEARCH

Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1–3 clinical trials: A Children’s Cancer and Leukaemia Group (CCLG) study

(2009) Boo Messahel et al.   EUROPEAN JOURNAL OF CANCER

Treatment of relapsed Wilms tumors: lessons learned

(2009) Filippo Spreafico et al.   Expert Review of Anticancer Therapy